Form 8-K - Current report:
SEC Accession No. 0001522767-25-000167
Filing Date
2025-08-06
Accepted
2025-08-06 17:10:18
Documents
14
Period of Report
2025-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrmd-20250806.htm   iXBRL 8-K 24638
2 EX-99.1 marimedq22025ex991.htm EX-99.1 301206
6 picture2.jpg GRAPHIC 8155
  Complete submission text file 0001522767-25-000167.txt   465155

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrmd-20250806.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrmd-20250806_lab.xml EX-101.LAB 20311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrmd-20250806_pre.xml EX-101.PRE 11505
16 EXTRACTED XBRL INSTANCE DOCUMENT mrmd-20250806_htm.xml XML 2512
Mailing Address 10 OCEANA WAY 2ND FLOOR NORWOOD MA 02062
Business Address 10 OCEANA WAY 2ND FLOOR NORWOOD MA 02062 781-277-0007
MARIMED INC. (Filer) CIK: 0001522767 (see all company filings)

EIN.: 274672745 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)